HER2 MUTATION INHIBITORS
This invention relates to compounds of Formula (I):and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein L1, L2, R1, R2, R3 and n are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ELLIS, Bryan Daniel PAJK, Spencer Phillip LAZZARA, Nicholas Charles NEWHOUSE, Bradley Jon LAIRD, Ellen Ruth HICKEN, Erik James GAUDINO, John Joseph BOYS, Mark Laurence |
| description | This invention relates to compounds of Formula (I):and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein L1, L2, R1, R2, R3 and n are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024124474A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024124474A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024124474A13</originalsourceid><addsrcrecordid>eNrjZJDwcA0yUvANDXEM8fT3U_D08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmhkYmJuYmjobGxKkCAHUOIKw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HER2 MUTATION INHIBITORS</title><source>esp@cenet</source><creator>ELLIS, Bryan Daniel ; PAJK, Spencer Phillip ; LAZZARA, Nicholas Charles ; NEWHOUSE, Bradley Jon ; LAIRD, Ellen Ruth ; HICKEN, Erik James ; GAUDINO, John Joseph ; BOYS, Mark Laurence</creator><creatorcontrib>ELLIS, Bryan Daniel ; PAJK, Spencer Phillip ; LAZZARA, Nicholas Charles ; NEWHOUSE, Bradley Jon ; LAIRD, Ellen Ruth ; HICKEN, Erik James ; GAUDINO, John Joseph ; BOYS, Mark Laurence</creatorcontrib><description>This invention relates to compounds of Formula (I):and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein L1, L2, R1, R2, R3 and n are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240418&DB=EPODOC&CC=US&NR=2024124474A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240418&DB=EPODOC&CC=US&NR=2024124474A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ELLIS, Bryan Daniel</creatorcontrib><creatorcontrib>PAJK, Spencer Phillip</creatorcontrib><creatorcontrib>LAZZARA, Nicholas Charles</creatorcontrib><creatorcontrib>NEWHOUSE, Bradley Jon</creatorcontrib><creatorcontrib>LAIRD, Ellen Ruth</creatorcontrib><creatorcontrib>HICKEN, Erik James</creatorcontrib><creatorcontrib>GAUDINO, John Joseph</creatorcontrib><creatorcontrib>BOYS, Mark Laurence</creatorcontrib><title>HER2 MUTATION INHIBITORS</title><description>This invention relates to compounds of Formula (I):and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein L1, L2, R1, R2, R3 and n are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDwcA0yUvANDXEM8fT3U_D08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmhkYmJuYmjobGxKkCAHUOIKw</recordid><startdate>20240418</startdate><enddate>20240418</enddate><creator>ELLIS, Bryan Daniel</creator><creator>PAJK, Spencer Phillip</creator><creator>LAZZARA, Nicholas Charles</creator><creator>NEWHOUSE, Bradley Jon</creator><creator>LAIRD, Ellen Ruth</creator><creator>HICKEN, Erik James</creator><creator>GAUDINO, John Joseph</creator><creator>BOYS, Mark Laurence</creator><scope>EVB</scope></search><sort><creationdate>20240418</creationdate><title>HER2 MUTATION INHIBITORS</title><author>ELLIS, Bryan Daniel ; PAJK, Spencer Phillip ; LAZZARA, Nicholas Charles ; NEWHOUSE, Bradley Jon ; LAIRD, Ellen Ruth ; HICKEN, Erik James ; GAUDINO, John Joseph ; BOYS, Mark Laurence</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024124474A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ELLIS, Bryan Daniel</creatorcontrib><creatorcontrib>PAJK, Spencer Phillip</creatorcontrib><creatorcontrib>LAZZARA, Nicholas Charles</creatorcontrib><creatorcontrib>NEWHOUSE, Bradley Jon</creatorcontrib><creatorcontrib>LAIRD, Ellen Ruth</creatorcontrib><creatorcontrib>HICKEN, Erik James</creatorcontrib><creatorcontrib>GAUDINO, John Joseph</creatorcontrib><creatorcontrib>BOYS, Mark Laurence</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ELLIS, Bryan Daniel</au><au>PAJK, Spencer Phillip</au><au>LAZZARA, Nicholas Charles</au><au>NEWHOUSE, Bradley Jon</au><au>LAIRD, Ellen Ruth</au><au>HICKEN, Erik James</au><au>GAUDINO, John Joseph</au><au>BOYS, Mark Laurence</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HER2 MUTATION INHIBITORS</title><date>2024-04-18</date><risdate>2024</risdate><abstract>This invention relates to compounds of Formula (I):and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein L1, L2, R1, R2, R3 and n are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2024124474A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | HER2 MUTATION INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T20%3A31%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ELLIS,%20Bryan%20Daniel&rft.date=2024-04-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024124474A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |